Загрузки by Drkrishnasarma pathy

OMCIJ.MS.ID.555853

Patent Evaluation on Monoclonal Antibody (MAB) Therapy with Binding Specificity to CD20 B-Cell Surface Antigen Bp35 and the Manufacturing Process of Biological &Antibodies and Derivatives

International Journal of Research Studies in Medical and Health Sciences-Antiviral nucleosides- Flu Viruses- QUINOLINES-COVID-19 Dr Krishna sarma pathy

HCV NS3/4A 3 Protease Inhibitors

BJSTR.MS.ID.003667 Chronic Hepatitis (Chc), Viral Polymerase Nucleotide Inhibitor & Process Patents Review and Evaluation, Preparation of Sofosbuvir

LOJMS.MS.ID.000121 An anti-inflammatory adrenocorticalsteroid Hydrocortisonesodiumsuccinate, hydrocortisone preparation and validated for the confirmation/ determination and quantification of hydrocortisone

An Anti-Inflammatory Adrenocorticalsteroid Hydrocortisonesodiumsuccinate, Hydrocortisone Preparation and Validated for the Confirmation Determination and Quantification of Hydrocortisone

loj

considerations

cefpodoxime

loj

bjstr.ms.id.001662considerations

considerations

bjstr.ms.id.001662considerations

JOJS.MS.ID.555566 (1)Case History-The Control of Impurities-A Critical Issue to The Active Pharmaceutical Ingredient

Case History-The Control of Impurities-A Critical Issue to The Active Pharmaceutical Ingredient JOJ Scin 1(4) JOJS.ms.ID.555566 (2018) Krishnasarmapathy

Krishnasarma Pathy K (2018) Entecavir Patent Evaluation & Genotoxicity

Herald Scholarly Open AccessPathy K (2018) Entecavir Patent Evaluation & Genotoxicity. J Toxicol Cur Res 2 005.

Krishnasarma Pathy K (2018) Entecavir Patent Evaluation & Genotoxicity

JPP-18-RA-1899-Entecavir-patent-evaluation--method--for-diastereomeric-Impurities--/1899

Httpswww.ommegaonline.orgarticle Details Entecavir Patent Evaluation Method for Diastereomeric Impurities 1899

Entecavir Patent Evaluation, Method for Diastereomeric Impurities OMCIJ.MS.ID.555711

Preparation of Vitamin C and Method for Determination of Vitamin C in Tablets SCSOAJ.ms.ID.000114

Route Evaluation and Analytical HPLC Method Development of Buprenorphine, Naloxone, And Comparison OverallSJFN.ms.ID.000105

OMCIJ.MS.ID.555674 .

SRMRCR-01-00014 (1)

OAJT.ms.ID.555593 Krishnasarmapathy

OAJT.ms.ID.555592krishnasarmapathy

Int J clinical & case. 1:7, 140-144-The influenza A virus subtypes H1N1, H1N2 and H3N2 ,HDFx

The influenza A virus subtypes H1N1, H1N2 and H3N2 ,HDFx

OAJT.MS.ID.555568 (1)Research Article Volume 1 Issue 4 - August 2017 DOI

OAJT.MS.ID.555568 (1)

Method Development and Pharmacological study of Chemotherapeutic Agents OAJT.ms.ID.555568 Drkrishnasarmapathy

BASIC SKILLS TRAINING GUIDE -HPLC method development and validation- an overview Dr Sarma Krishna pathy ,YLN Murthy,Sunithasarma,Atchuutha ramaiah

BASIC SKILLS TRAINING GUIDE -HPLC Method Development and Validation- An Overview-1

S- Amlo Besylate

Industrial process for OXICONAZOLE Dr krishnasarma Pathy step-I 2,2’4’-tri-choloroacetophenone,Imidazole reacted in presence of acetonitrile to form 1-(2,4-dichlorophenacyl)-imidazole (I).Which is then reacted with hydroxylamine. hydrochloride to give (Z)-1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl) ethanone oxime (II). It is further reacted with 2,4-Dichlorobenzyl chloride in presence of sodium hydride to give (III) Oxiconazole and finally salt formation with nitric acid

Article

Lab Notebook Example-Tris[(2-pyridyl)methyl]amine

IPR - A Primer on Intellectual Property Rights-Dr KrishnasarmaPathy

Solid-state Forms of Celecoxib and an Improved Process for the Preparation of Celecoxib Polymorph

CELECOXIB

Industrial process for preparation of Levetiracetam.

Levi Trace Tam

Industrial process for preparation of Levetiracetam.

Levi Trace Tam

VITAMIN C

PHENYLEPHRINE

DEFINITION “IMPURITY”